Amphastar Pharmaceuticals, Inc. (AMPH) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMPH
Amphastar Pharmaceuticals, Inc.
$25.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$11.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AMPH vs ORIC
growth of $100 · dividends reinvested · last 6yAMPH +51.6% (+7.2%/yr)ORIC -51.5% (-11.4%/yr)AMPH compounded faster over this window
AMPH ORIC
AMPH vs ORIC: by the numbers
- •ORIC is the larger company ($1.24B vs $1.14B market cap).
- •AMPH is profitable (10.76% net margin) while ORIC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AMPH | ORIC |
|---|---|---|
| P/E ratio | 15.33 | N/A |
| Forward P/E | 8.72 | N/A |
| PEG ratio | 0.11 | N/A |
| P/S ratio | 1.56 | N/A |
| P/B ratio | 1.49 | 3.25 |
| EV / EBITDA | 8.95 | N/A |
| FCF yield | 13.38% | N/A |
Profitability
| Metric | AMPH | ORIC |
|---|---|---|
| Gross margin | 47.68% | 0.00% |
| Operating margin | 15.66% | 0.00% |
| Net margin | 10.76% | 0.00% |
| ROE | 10.23% | -36.81% |
| ROIC | 5.93% | -40.32% |
Growth (annualized)
| Metric | AMPH | ORIC |
|---|---|---|
| Revenue CAGR (5Y) | 13.71% | N/A |
| EPS CAGR (5Y) | 134.23% | N/A |
| FCF CAGR (5Y) | 23.90% | N/A |
| Total return CAGR (5Y) | 6.13% | -8.73% |
Frequently asked
- Is AMPH or ORIC more profitable?
- AMPH runs the higher net margin — AMPH at 10.76% versus ORIC at 0.00%.
- How have AMPH and ORIC total returns compared?
- Over the past 5 years, AMPH delivered 6.13% and ORIC delivered -8.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEORIC Pharmaceuticals ROEAmphastar Pharmaceuticals operating marginORIC Pharmaceuticals operating marginAmphastar Pharmaceuticals revenue growthORIC Pharmaceuticals revenue growthAmphastar Pharmaceuticals free cash flowORIC Pharmaceuticals free cash flow
Amphastar Pharmaceuticals & ORIC Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.